ChromaDex Q3 2023 Gaap EPS $(0.01) Beats $(0.03) Estimate, Sales $19.50M Miss $20.25M Estimate
Author: Benzinga Newsdesk | November 08, 2023 05:46pm
ChromaDex (NASDAQ:
CDXC) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 66.67 percent. This is a 75 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $19.50 million which missed the analyst consensus estimate of $20.25 million by 3.73 percent. This is a 14.25 percent increase over sales of $17.06 million the same period last year.
Posted In: CDXC